Cyclopharm Share Price and Company Fundamentals



Price
$0.96
Change
-0.210 (-17.949%)
52 week range
0.56 - 2.44

Last traded: Today at 5:11 AM

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

Key Metrics

PE ratio

-

PB ratio

2.95

Dividend yield

-

Beta

0.91

Market cap

$106.69M

Enterprise value

$102.26M

Company profile

Industry / Sector Medical Distribution / Healthcare
Full time employees 97
Website https://www.cyclomedica.com/company/cyclopharm/
Mailing address 1 The Crescent Unit 4 Kingsgrove NSW 2208 Australia
Phone / Fax 61 2 9541 0411 / 61 2 9543 0960

Dividends

More: Cyclopharm Dividend history, yield and payout ratio

Dividend yield

-

Dividend amount

$-

Payout ratio

0.00%

5Y Avg. yield

-%

Cyclopharm paid $- dividend and the ex-dividend date was 01 Sep 2023.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CYC dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Feb 2026, following are the company executives and directors listed on Cyclopharm.

Name Title Age Total Pay
Mr. James S. McBrayer AIM, BSPharm, F.A.C.I.D., FAICD, GDM CEO, MD, Company Secretary & Director 60
Mr. Jason Smith Chief Financial Officer
Mr. Mathew Farag Chief Operating Officer
Ms. Sally-Ann Cornelius Head of Sales
Ms. Niamh McAree Head of Quality and Regulatory
Mr. Chris Quinn Head of Service
Ms. Sui Ling Cheah Financial Controller 55
Mr. Lynn McLauchlin General Manager of Canada
Mr. Gary T. Somerville Quality & Regulatory Manager

Profitability and management effectiveness

Profit margin

-43.54%

Operating margin

-57.20%

Return on assets

-15.65%

Return on equity

-31.98%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Cyclopharm is 106.69M and its enterprise value is 102.26M. The enterprise value to revenue ratio of CYC is 3.33. The enterprise value to EBITDA ratio of CYC is -7.27.

The CYC's stocks Beta value is 0.91 making it 9% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Cyclopharm (CYC)

Cyclopharm (ASX:CYC) Frequently Asked Questions

1. What is Cyclopharm's Stock Symbol?

Cyclopharm trades on ASX under the ticker symbol "CYC".

2. What is Cyclopharm's stock price today?

One share of CYC stock can currently be purchased for approximately $0.96.

3. How can I contact Cyclopharm?

Cyclopharm's mailing address is 1 The Crescent Unit 4 Kingsgrove NSW 2208 Australia. The company can be reached via phone at 61 2 9541 0411.

4. What is Cyclopharm's official website?

The official website of Cyclopharm is https://www.cyclomedica.com/company/cyclopharm/.